LEUKEMIA, MYELOID, ACUTE
Clinical trials for LEUKEMIA, MYELOID, ACUTE explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOID, ACUTE trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOID, ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a fourth drug tip the scales against an aggressive leukemia?
⭐️ CURE ⭐️ Not yet recruitingThis trial is testing whether adding venetoclax to standard intensive chemotherapy plus midostaurin can improve outcomes for adults with a type of acute myeloid leukemia that has a FLT3 mutation. The study enrolls people aged 18 to 70 with newly diagnosed disease who are healthy …
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: ⭐️ CURE ⭐️
Last updated Jul 26, 2026 00:00 UTC
-
New drug combination targets rare childhood leukemia that resists standard treatment
Disease control Not yet recruitingThis trial tests whether adding the drug revumenib to standard chemotherapy (fludarabine and cytarabine) can help children and young adults with a rare form of acute myeloid leukemia (AML) that has come back or not responded to treatment. The study enrolls up to 27 participants a…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE2 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New transplant method aims to cut dangerous side effects in blood cancer patients
Disease control Not yet recruitingThis study tests a special way to process donated stem cells to make transplants safer for people with leukemia or lymphoma. The goal is to reduce serious complications like graft-versus-host disease, where donor cells attack the patient's body. About 100 participants will receiv…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE2 • Sponsor: Guenther Koehne • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Engineered t cells take aim at stubborn leukemias in early trial
Disease control Not yet recruitingThis early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Computer vs expert: can AI match humans in finding hidden leukemia?
Diagnosis Not yet recruitingThis study looks at 60 people with acute myeloid leukemia to see if a computer method (FlowSOM) can detect leftover cancer cells as well as expert analysis. Researchers will compare results from both methods using stored blood samples. If the computer approach works, it could mak…
Matched conditions: LEUKEMIA, MYELOID, ACUTE
Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC